Camp4 Therapeutics (CAMP) Payables (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Payables data on file, last reported at $863000.0 in Q1 2026.

• For the quarter ending Q1 2026, Payables changed N/A year-over-year to $863000.0; the trailing twelve-month figure through Mar 2026 stood at $863000.0 (changed N/A YoY), and the FY2025 full-year result was $182000.0, down 84.96% from the prior year.
• Payables advanced to $863000.0 in Q1 2026, from $182000.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $3.9 million in Q3 2024 to a low of $182000.0 in Q4 2025.
• A 4-year average of $1.3 million and a median of $1.0 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables gained 16.12% in 2024 and sank 84.96% in 2025, its largest moves.
• Tracing CAMP's Payables over 4 years: stood at $1.0 million in 2023, then increased by 16.12% to $1.2 million in 2024, then slumped by 84.96% to $182000.0 in 2025, then jumped by 374.18% to $863000.0 in 2026.
• Business Quant data shows CAMP's Payables at $863000.0 in Q1 2026, $182000.0 in Q4 2025, and $585000.0 in Q3 2025.